Advertisement

Psychopharmacology

, Volume 235, Issue 8, pp 2447–2457 | Cite as

Binge-like acquisition of α-pyrrolidinopentiophenone (α-PVP) self-administration in female rats

  • Mehrak Javadi-Paydar
  • Eric L. Harvey
  • Yanabel Grant
  • Sophia A. Vandewater
  • Kevin M. Creehan
  • Jacques D. Nguyen
  • Tobin J. Dickerson
  • Michael A. Taffe
Original Investigation

Abstract

Rationale

The synthetic cathinone α-pyrrolidinopentiophenone (α-PVP) has been associated with bizarre public behavior in users. Association of such behavior with extended binges of drug use motivates additional investigation, particularly since a prior study found that half of male rats experience a binge of exceptionally high intake, followed by sustained lower levels of self-administration during the acquisition of intravenous self-administration (IVSA) of a related drug, 3,4-methylenedioxypyrovalerone.

Objectives

The binge-like acquisition pattern is novel for rat IVSA; thus, the present study sought to determine if this effect generalizes to IVSA of α-PVP in female rats.

Methods

Female Wistar rats were trained in IVSA of α-PVP (0.05 mg/kg/inf) in experimental chambers containing an activity wheel. Groups were trained with the wheels fixed (No-Wheel group), fixed for the initial 5 days of acquisition or free to move throughout acquisition (Wheel group). The groups were next subjected to a wheel access switch and then all animals to dose-substitution (0.0125–0.3 mg/kg/inf) with the wheels alternately fixed and free to move.

Results

Approximately half of the rats initiated their IVSA pattern with a binge day of exceptionally high levels of drug intake, independent of wheel access condition. Wheel activity was much lower in the No-Wheel group in the wheel switch post-acquisition. Dose-effect curves were similar for wheel access training groups, for binge/no binge phenotypic subgroups and were not altered with wheel access during the dose-substitution.

Conclusion

This confirms the high reinforcer effectiveness of α-PVP in female rats and the accompanying devaluation of wheel activity as a naturalistic reward.

Keywords

Reward “Bath salts” Psychostimulants Synthetic drugs Wheel running 

Notes

Acknowledgements

This work was funded by support from the US Public Health Service National Institutes of Health (R01DA042211) which had no direct input on the design, conduct, analysis, or publication of the findings. Conception and securing funding for the project: MAT, TJD; study design: MAT, MJ-P, JDN; data collection and initial analysis: MJ-P, ELH, YG, SAV, KMC, JDN; statistical analysis and figure creation: MAT; manuscript drafting: MAT, MJ-P. All authors have read and approved the manuscript. The authors declare no competing financial interests. This is manuscript #29574 from The Scripps Research Institute.

Compliance with ethical standards

All experimental procedures were conducted under protocols approved by the Institutional Care and Use Committees of The Scripps Research Institute and in a manner consistent with the Guide for the Care and Use of Laboratory Animals (National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals. et al. 2011).

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Aarde SM, Huang PK, Creehan KM, Dickerson TJ, Taffe MA (2013) The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 71:130–140CrossRefPubMedPubMedCentralGoogle Scholar
  2. Aarde SM, Creehan KM, Vandewater SA, Dickerson TJ, Taffe MA (2015a) In vivo potency and efficacy of the novel cathinone alpha-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats. Psychopharmacology 232:3045–3055CrossRefPubMedPubMedCentralGoogle Scholar
  3. Aarde SM, Huang PK, Dickerson TJ, Taffe MA (2015b) Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats. Psychopharmacology 232:1867–1877CrossRefPubMedGoogle Scholar
  4. Aarde SM, Miller ML, Creehan KM, Vandewater SA, Taffe MA (2015c) One day access to a running wheel reduces self-administration of D-methamphetamine, MDMA and methylone. Drug Alcohol Depend 151:151–158CrossRefPubMedPubMedCentralGoogle Scholar
  5. Alvarez SC, Benz GR, Elder R, Lew M, Sneider J (2012) Intervention season 12, episode 8: Skyler & Jessa. In: Mettler S (ed) intervention. A & E, aetv.com
  6. Anderson C (2015) Flakka, synthetic drug behind increasingly bizarre crimes. Associated Press, http://hosted.ap.org/dynamic/stories/U/US_FLAKKAS_EMERGENCE: http://hosted.ap.org/dynamic/stories/U/US_FLAKKAS_EMERGENCE
  7. Angoa-Perez M, Anneken JH, Kuhn DM (2017) Neurotoxicology of synthetic cathinone analogs. Curr Top Behav Neurosci 32:209–230CrossRefPubMedGoogle Scholar
  8. Anker JJ, Carroll ME (2011) Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci 8:73–96CrossRefPubMedGoogle Scholar
  9. Anneken JH, Angoa-Perez M, Kuhn DM (2015) 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: beta-ketoamphetamine modulation of neurotoxicity by the dopamine transporter. J Neurochem 133:211–222CrossRefPubMedPubMedCentralGoogle Scholar
  10. Antonowicz JL, Metzger AK, Ramanujam SL (2011) Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases. Gen Hosp Psychiatry 33(640):e5–e6Google Scholar
  11. Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products. Neuropsychopharmacology 38:552–562CrossRefPubMedGoogle Scholar
  12. Benzie F, Hekman K, Cameron L, Wade DR, Smolinske S (2011) Emergency department visits after use of a drug sold as "bath salts"—Michigan, November 13, 2010–March 31, 2011. MMWR Morb Mortal Wkly Rep 60:624–627Google Scholar
  13. Borek HA, Holstege CP (2012) Hyperthermia and multiorgan failure after abuse of “bath salts” containing 3,4-methylenedioxypyrovalerone. Ann Emerg Med 60:103–105CrossRefPubMedGoogle Scholar
  14. Cosgrove KP, Hunter RG, Carroll ME (2002) Wheel-running attenuates intravenous cocaine self-administration in rats: sex differences. Pharmacol Biochem Behav 73:663–671CrossRefPubMedGoogle Scholar
  15. Creehan KM, Vandewater SA, Taffe MA (2015) Intravenous self-administration of mephedrone, methylone and MDMA in female rats. Neuropharmacology 92:90–97CrossRefPubMedPubMedCentralGoogle Scholar
  16. DePoy LM, Allen AG, Gourley SL (2016) Adolescent cocaine self-administration induces habit behavior in adulthood: sex differences and structural consequences. Transl Psychiatry 6:e875CrossRefPubMedPubMedCentralGoogle Scholar
  17. Gannon BM, Galindo KI, Rice KC, Collins GT (2017) Individual differences in the relative reinforcing effects of 3,4-methylenedioxypyrovalerone under fixed and progressive ratio schedules of reinforcement in rats. J Pharmacol Exp Ther 361:181–189CrossRefPubMedPubMedCentralGoogle Scholar
  18. Gannon BM, Galindo KI, Mesmin MP, Sulima A, Rice KC, Collins GT (2018) Relative reinforcing effects of second-generation synthetic cathinones: acquisition of self-administration and fixed ratio dose-response curves in rats. Neuropharmacology 134(Pt A):28–35CrossRefPubMedGoogle Scholar
  19. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). Pharmacol Rev 55:463–508CrossRefPubMedGoogle Scholar
  20. Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, Andrenyak DM, Vieira-Brock PL, German CL, Conrad KM, Hoonakker AJ, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE (2011) 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 339:530–536CrossRefPubMedPubMedCentralGoogle Scholar
  21. Hubscher CH, Brooks DL, Johnson JR (2005) A quantitative method for assessing stages of the rat estrous cycle. Biotech Histochem : Off Publ Biol Stain Commission 80:79–87CrossRefGoogle Scholar
  22. Javadi-Paydar M, Nguyen JD, Vandewater SA, Dickerson TJ, Taffe MA (2018) Locomotor and reinforcing effects of pentedrone, pentylone and methylone in rats. Neuropharmacology 134(Pt A):57–64CrossRefPubMedGoogle Scholar
  23. Lynch WJ (2018) Modeling the development of drug addiction in male and female animals. Pharmacol Biochem Behav 164:50–61.CrossRefPubMedGoogle Scholar
  24. Lynch WJ, Carroll ME (1999) Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats. Psychopharmacology 144:77–82CrossRefPubMedGoogle Scholar
  25. Lynch WJ, Arizzi MN, Carroll ME (2000) Effects of sex and the estrous cycle on regulation of intravenously self-administered cocaine in rats. Psychopharmacology 152:132–139CrossRefPubMedGoogle Scholar
  26. Marcondes FK, Bianchi FJ, Tanno AP (2002) Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol = Rev Bras Biol 62:609–614Google Scholar
  27. Marusich JA, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH (2014) Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87:206–213CrossRefPubMedPubMedCentralGoogle Scholar
  28. McFadden LM, Hoonakker AJ, Vieira-Brock PL, Stout KA, Sawada NM, Ellis JD, Allen SC, Walters ET, Nielsen SM, Gibb JW, Alburges ME, Wilkins DG, Hanson GR, Fleckenstein AE (2011) Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration. Synapse 65:771–777CrossRefPubMedPubMedCentralGoogle Scholar
  29. Miller ML, Vaillancourt BD, Wright MJ Jr, Aarde SM, Vandewater SA, Creehan KM, Taffe MA (2012) Reciprocal inhibitory effects of intravenous d-methamphetamine self-administration and wheel activity in rats. Drug Alcohol Depend 121:90–96CrossRefPubMedGoogle Scholar
  30. Miller ML, Moreno AY, Aarde SM, Creehan KM, Vandewater SA, Vaillancourt BD, Wright MJ Jr, Janda KD, Taffe MA (2013) A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats. Biol Psychiatry 73:721–728CrossRefPubMedGoogle Scholar
  31. Miller MM, Meyer AE, Sprowles JL, Sable HJ (2017) Cocaine self-administration in male and female rats perinatally exposed to PCBs: evaluating drug use in an animal model of environmental contaminant exposure. Exp Clin Psychopharmacol 25:114–124CrossRefPubMedPubMedCentralGoogle Scholar
  32. Miner NB, O'Callaghan JP, Phillips TJ, Janowsky A (2017) The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity. Neurotoxicol Teratol 61:74–81CrossRefPubMedPubMedCentralGoogle Scholar
  33. National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals., Institute for Laboratory Animal Research (U.S.), National Academies Press (U.S.) (2011) Guide for the care and use of laboratory animals: Eigth Edition. National Academies Press,, Washington, D.C., pp xxv, 220 pGoogle Scholar
  34. Nguyen JD, Grant Y, Creehan KM, Vandewater SA, Taffe MA (2017) Escalation of intravenous self-administration of methylone and mephedrone under extended access conditions. Addict Biol 22:1160–1168CrossRefPubMedGoogle Scholar
  35. Penders TM, Gestring R (2011) Hallucinatory delirium following use of MDPV: “bath salts”. Gen Hosp Psychiatry 33:525–526CrossRefPubMedGoogle Scholar
  36. Perry AN, Westenbroek C, Becker JB (2013) The development of a preference for cocaine over food identifies individual rats with addiction-like behaviors. PLoS One 8:e79465CrossRefPubMedPubMedCentralGoogle Scholar
  37. Ramoa CP, Doyle SE, Naim DW, Lynch WJ (2013) Estradiol as a mechanism for sex differences in the development of an addicted phenotype following extended access cocaine self-administration. Neuropsychopharmacol : Off Publ Am Coll Neuropsychopharmacol 38:1698–1705CrossRefGoogle Scholar
  38. Reichel CM, Chan CH, Ghee SM, See RE (2012) Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats. Psychopharmacology 223:371–380CrossRefPubMedPubMedCentralGoogle Scholar
  39. Ricaurte GA, McCann UD (1992) Neurotoxic amphetamine analogues: effects in monkeys and implications for humans. Ann N Y Acad Sci 648:371–382CrossRefPubMedGoogle Scholar
  40. Roth ME, Carroll ME (2004a) Sex differences in the acquisition of IV methamphetamine self-administration and subsequent maintenance under a progressive ratio schedule in rats. Psychopharmacology 172:443–449CrossRefPubMedGoogle Scholar
  41. Roth ME, Carroll ME (2004b) Sex differences in the escalation of intravenous cocaine intake following long- or short-access to cocaine self-administration. Pharmacol Biochem Behav 78:199–207CrossRefPubMedGoogle Scholar
  42. Sarkar S, Schmued L (2010) Neurotoxicity of ecstasy (MDMA): an overview. Curr Pharm Biotechnol 11:460–469CrossRefPubMedGoogle Scholar
  43. Schindler CW, Thorndike EB, Goldberg SR, Lehner KR, Cozzi NV, Brandt SD, Baumann MH (2016) Reinforcing and neurochemical effects of the “bath salts” constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology 233:1981–1990CrossRefPubMedGoogle Scholar
  44. Sewalia K, Watterson LR, Hryciw A, Belloc A, Ortiz JB, Foster Olive M (2018) Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 134(Pt A):36–45CrossRefPubMedGoogle Scholar
  45. Smethells JR, Swalve NL, Eberly LE, Carroll ME (2016) Sex differences in the reduction of impulsive choice (delay discounting) for cocaine in rats with atomoxetine and progesterone. Psychopharmacology 233:2999–3008CrossRefPubMedPubMedCentralGoogle Scholar
  46. Smith MA, Witte MA (2012) The effects of exercise on cocaine self-administration, food-maintained responding, and locomotor activity in female rats: importance of the temporal relationship between physical activity and initial drug exposure. Exp Clin Psychopharmacol 20:437–446CrossRefPubMedPubMedCentralGoogle Scholar
  47. Smith MA, Walker KL, Cole KT, Lang KC (2011) The effects of aerobic exercise on cocaine self-administration in male and female rats. Psychopharmacology 218:357–369CrossRefPubMedPubMedCentralGoogle Scholar
  48. Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clin Toxicol(Philadelphia, Pa) 49:499–505Google Scholar
  49. Swalve N, Smethells JR, Carroll ME (2016a) Sex differences in the acquisition and maintenance of cocaine and nicotine self-administration in rats. Psychopharmacology 233:1005–1013CrossRefPubMedGoogle Scholar
  50. Swalve N, Smethells JR, Zlebnik NE, Carroll ME (2016b) Sex differences in reinstatement of cocaine-seeking with combination treatments of progesterone and atomoxetine. Pharmacol Biochem Behav 145:17–23CrossRefPubMedPubMedCentralGoogle Scholar
  51. Taffe MA, Davis SA, Yuan J, Schroeder R, Hatzidimitriou G, Parsons LH, Ricaurte GA, Gold LH (2002) Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge. Neuropsychopharmacology 27:993–1005CrossRefPubMedGoogle Scholar
  52. Umebachi R, Aoki H, Sugita M, Taira T, Wakai S, Saito T, Inokuchi S (2016) Clinical characteristics of alpha-pyrrolidinovalerophenone (alpha-PVP) poisoning. Clinical toxicology (Philadelphia, Pa) 54: 563–567Google Scholar
  53. Vandewater SA, Creehan KM, Taffe MA (2015) Intravenous self-administration of entactogen-class stimulants in male rats. Neuropharmacology 99:538–545CrossRefPubMedPubMedCentralGoogle Scholar
  54. Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Grabenauer M, Thomas BF, Marusich JA, Wegner S, Olive MF (2014) Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol 19:165–174CrossRefPubMedGoogle Scholar
  55. Wurita A, Hasegawa K, Minakata K, Gonmori K, Nozawa H, Yamagishi I, Suzuki O, Watanabe K (2014) Postmortem distribution of alpha-pyrrolidinobutiophenone in body fluids and solid tissues of a human cadaver. Legal Med 16:241–246CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Mehrak Javadi-Paydar
    • 1
  • Eric L. Harvey
    • 1
  • Yanabel Grant
    • 1
  • Sophia A. Vandewater
    • 1
  • Kevin M. Creehan
    • 1
  • Jacques D. Nguyen
    • 1
  • Tobin J. Dickerson
    • 2
  • Michael A. Taffe
    • 1
  1. 1.Department of NeuroscienceThe Scripps Research InstituteLa JollaUSA
  2. 2.Department of ChemistryThe Scripps Research InstituteLa JollaUSA

Personalised recommendations